IMAX
Trust-weighted public proof page for IMAX. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.
Recent proof-backed thesis calls
Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.
Fragmented interview snippet with IMAX CEO Richard Gelfond referencing strong sell-outs for "The Odyssey" (e.g., TCL LA, London BFI 6 a.m.) and mentioning film/digital/movie tech. Limited concrete financial or forward-looking details, but implies strong premium-format demand for a specific title and IMAX programming strength.
Risk-off session: S&P 500 broadly down (~337 decliners). Middle East escalation narrative pushed WTI above $83/bbl. Mega-cap tech (Alphabet, Amazon, Microsoft) sold off around earnings week. Media names weak; Warner Bros. Discovery closed at its lowest since Dec. 4. Mixed media/streaming chatter included higher Netflix price targets post-earnings. Sweetgreen referenced as sliding; IMAX mentioned as having a tougher tape.
Current stance
- risk via Media complex under pressure; WBD technical weakness may spill over to adjacent names from https://www.youtube.com/channel/UCIALMKvObZNtJ6AmdCLP7Lg (confidence 0.50)
- buy via Near-term sentiment tailwind for IMAX from sold-out premium screenings tied to a marquee release from https://www.youtube.com/channel/UCIALMKvObZNtJ6AmdCLP7Lg (confidence 0.42)
Top authors on this asset
Active and historical ticker theses
Media complex under pressure; WBD technical weakness may spill over to adjacent names
Near-term sentiment tailwind for IMAX from sold-out premium screenings tied to a marquee release
Unlock full asset monitoring
Create an account to access full asset history, alerts, Telegram workflows, and trust-weighted live rankings across authors, ticker theses, and market events.